Systematic Review and Meta-Analysis of the Prognostic Value of Serum High-Density Lipoprotein Cholesterol Levels for Solid Tumors

References

• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, et al.: Global cancer statistics, 2012. CA Cancer J Clin 65, 87–108, 2015.
   PubMed Web of Science ®Google Scholar
• Fiorenza AM, Branchi A, and Sommariva D: Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects. Int J Clin Lab Res 30, 141–145, 2000.
   PubMedGoogle Scholar
• Fonseca J, Santos CA, and Brito J: Malnutrition and clinical outcome of 234 head and neck cancer patients who underwent percutaneous endoscopic gastrostomy. Nutr Cancer 68, 589–597, 2016.
   PubMed Web of Science ®Google Scholar
• Nofer JR, Junker R, Pulawski E, Fobker M, Levkau B, et al.: High density lipoproteins induce cell cycle entry in vascular smooth muscle cells via mitogen activated protein kinase-dependent pathway. Thromb Haemost 85, 730–735, 2001.
   PubMed Web of Science ®Google Scholar
• Nofer JR, Levkau B, Wolinska I, Junker R, Fobker M, et al.: Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids. J Biol Chem 276, 34480–34485, 2001.
   PubMed Web of Science ®Google Scholar
• Zannis VI, Chroni A, Kypreos KE, Kan HY, Cesar TB, et al.: Probing the pathways of chylomicron and HDL metabolism using adenovirus-mediated gene transfer. Curr Opin Lipidol 15, 151–166, 2004.
   PubMed Web of Science ®Google Scholar
• Zannis VI, Cole FS, Jackson CL, Kurnit DM, and Karathanasis SK: Distribution of apolipoprotein A-I, C-II, C-III, and E mRNA in fetal human tissues. Time-dependent induction of apolipoprotein E mRNA by cultures of human monocyte-macrophages. Biochemistry 24, 4450–4455, 1985.
   PubMed Web of Science ®Google Scholar
• Braschi S, Couture N, Gambarotta A, Gauthier BR, Coffill CR, et al.: Hepatic lipase affects both HDL and ApoB-containing lipoprotein levels in the mouse. Biochim Biophys Acta 1392, 276–290, 1998.
   PubMed Web of Science ®Google Scholar
• Ishida T, Choi S, Kundu RK, Hirata K, Rubin EM, et al.: Endothelial lipase is a major determinant of HDL level. J Clin Invest 111, 347–355, 2003.
   PubMed Web of Science ®Google Scholar
• Barter PJ, Brewer HB, Jr., Chapman MJ, Hennekens CH, Rader DJ, et al.: Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis. Arterioscler Thromb Vasc Biol 23, 160–167, 2003.
   PubMed Web of Science ®Google Scholar
• Ji Y, Jian B, Wang N, Sun Y, Moya ML, et al.: Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J Biol Chem 272, 20982–20985, 1997.
   PubMed Web of Science ®Google Scholar
• Gillotte-Taylor K, Boullier A, Witztum JL, Steinberg D, and Quehenberger O: Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein. J Lipid Res 42, 1474–1482, 2001.
   PubMed Web of Science ®Google Scholar
• Esteve E, Ricart W, and Fernandez-Real JM: Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin Nutr 24, 16–31, 2005.
   PubMed Web of Science ®Google Scholar
• Coussens LM, and Werb Z: Inflammation and cancer. Nature 420, 860–867, 2002.
   PubMed Web of Science ®Google Scholar
• Wallberg-Jonsson S, Dahlen G, Johnson O, Olivecrona G, and Rantapaa-Dahlqvist S: Lipoprotein lipase in relation to inflammatory activity in rheumatoid arthritis. J Intern Med 240, 373–380, 1996.
   PubMed Web of Science ®Google Scholar
• Tietge UJ, Maugeais C, Cain W, and Rader DJ: Acute inflammation increases selective uptake of HDL cholesteryl esters into adrenals of mice overexpressing human sPLA2. Am J Physiol Endocrinol Metab 285, E403–E411, 2003.
   PubMed Web of Science ®Google Scholar
• Levy E, Gurbindo C, Lacaille F, Paradis K, Thibault L, et al.: Circulating tumor necrosis factor-alpha levels and lipid abnormalities in patients with cystic fibrosis. Pediatr Res 34, 162–166, 1993.
   PubMed Web of Science ®Google Scholar
• Kritchevsky SB, Wilcosky TC, Morris DL, Truong KN, and Tyroler HA: Changes in plasma lipid and lipoprotein cholesterol and weight prior to the diagnosis of cancer. Cancer Res 51, 3198–3203, 1991.
   PubMed Web of Science ®Google Scholar
• Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, et al.: Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 355, 763–778, 2006.
   PubMed Web of Science ®Google Scholar
• Li X, Tang H, Wang J, Xie X, Liu P, et al.: The effect of preoperative serum triglycerides and high-density lipoprotein-cholesterol levels on the prognosis of breast cancer. Breast 32, 1–6, 2017.
   PubMed Web of Science ®Google Scholar
• Tamura T, Inagawa S, Hisakura K, Enomoto T, and Ohkohchi N: Evaluation of serum high-density lipoprotein cholesterol levels as a prognostic factor in gastric cancer patients. J Gastroenterol Hepatol 27, 1635–1640, 2012.
   PubMed Web of Science ®Google Scholar
• Jiang SS, Weng DS, Jiang L, Zhang YJ, Pan K, et al.: The clinical significance of preoperative serum cholesterol and high-density lipoprotein-cholesterol levels in hepatocellular carcinoma. J Cancer 7, 626–632, 2016.
   PubMed Web of Science ®Google Scholar
• Liu YY, Lin SJ, Chen YY, Liu LN, Bao LB, et al.: High-density lipoprotein cholesterol as a predictor of poor survival in patients with nasopharyngeal carcinoma. Oncotarget 7, 42978–42987, 2016.
   PubMedGoogle Scholar
• Wang XP, Li XH, Zhang L, Lin JH, Huang H, et al.: High level of serum apolipoprotein A-I is a favorable prognostic factor for overall survival in esophageal squamous cell carcinoma. BMC Cancer 16, 516, 2016.
   PubMed Web of Science ®Google Scholar
• Parmar MK, Torri V, and Stewart L: Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17, 2815–2834, 1998.
   PubMed Web of Science ®Google Scholar
• Tierney JF, Stewart LA, Ghersi D, Burdett S, and Sydes MR: Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8, 16, 2007.
   PubMed Web of Science ®Google Scholar
• Higgins JP, and Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 21, 1539–1558, 2002.
   PubMed Web of Science ®Google Scholar
• Guo S, He X, Chen Q, Yang G, Yao K, et al.: The effect of preoperative apolipoprotein A-I on the prognosis of surgical renal cell carcinoma: a retrospective large sample study. Medicine (Baltimore) 95, e3147, 2016.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xu J, Lou Y, Hu S, Yu K, et al.: Pretreatment direct bilirubin and total cholesterol are significant predictors of overall survival in advanced non-small-cell lung cancer patients with EGFR mutations. Int J Cancer 140, 1645–1652, 2017.
   PubMed Web of Science ®Google Scholar
• Liu BZ, Tao L, Chen YZ, Li XZ, Dong YL, et al.: Preoperative body mass index, blood albumin and triglycerides predict survival for patients with gastric cancer. PLoS One 11, e0157401, 2016.
   PubMed Web of Science ®Google Scholar
• You J, Liu WY, Zhu GQ, Wang OC, Ma RM, et al.: Metabolic syndrome contributes to an increased recurrence risk of non-metastatic colorectal cancer. Oncotarget 6, 19880–19890, 2015.
   PubMedGoogle Scholar
• Chi PD, Liu W, Chen H, Zhang JP, Lin Y, et al.: High-density lipoprotein cholesterol is a favorable prognostic factor and negatively correlated with C-reactive protein level in non-small cell lung carcinoma. PLoS One 9, e91080, 2014.
   PubMed Web of Science ®Google Scholar
• Wolfe AR, Atkinson RL, Reddy JP, Debeb BG, Larson R, et al.: High-density and very-low-density lipoprotein have opposing roles in regulating tumor-initiating cells and sensitivity to radiation in inflammatory breast cancer. Int J Radiat Oncol Biol Phys 91, 1072–1080, 2015.
   PubMed Web of Science ®Google Scholar
• Que Y, Jiang F, Liu L, Li Y, Chen Y, et al.: Clinical significance of preoperative serum high density lipoprotein cholesterol levels in soft tissue sarcoma. Medicine (Baltimore) 94, e844, 2015.
   PubMed Web of Science ®Google Scholar
• Fan Y, Ding X, Wang J, Ma F, Yuan P, et al.: Decreased serum HDL at initial diagnosis correlates with worse outcomes for triple-negative breast cancer but not non-TNBCs. Int J Biol Markers 30, 200–207, 2015.
   Web of Science ®Google Scholar
• Wei XL, Qiu MZ, Lin HX, Zhang Y, Liu JX, et al.: Patients with old age or proximal tumors benefit from metabolic syndrome in early stage gastric cancer. PLoS One 9, e89965, 2014.
   PubMed Web of Science ®Google Scholar
• Zou L, Liu TR, and Yang AK: Metabolic syndrome is associated with better prognosis in patients with tongue squamous cell carcinoma. Chin J Cancer 34, 184–188, 2015.
   PubMedGoogle Scholar
• Chen P, Han L, Wang C, Jia Y, Song Q, et al.: Preoperative serum lipids as prognostic predictors in esophageal squamous cell carcinoma patients with esophagectomy. Oncotarget 8, 41605–41619, 2017.
   PubMedGoogle Scholar
• Wang Y, Wen XZ, Ba HJ, Ding Y, Li DD, et al.: The prognostic value of preoperative serum HDL cholesterol in patients with resectable acral melanoma. Int J Clin Exp Med 10, 5134–5142, 2017.
   Web of Science ®Google Scholar
• Tian L, Yu Q, Gao XH, Wu J, Ma XL, et al.: A new use for an old index: preoperative high-density lipoprotein predicts recurrence in patients with hepatocellular carcinoma after curative resections. Lipids Health Dis 16, 123, 2017.
   PubMed Web of Science ®Google Scholar
• Peng F, Hu D, Lin X, Chen G, Liang B, et al.: Analysis of preoperative metabolic risk factors affecting the prognosis of patients with esophageal squamous cell carcinoma: the Fujian Prospective Investigation of Cancer (FIESTA) study. EBioMedicine 16, 115–123, 2017.
   PubMed Web of Science ®Google Scholar
• Liang R, Li J, Li M, Yang Y, Wang X, et al.: Clinical significance of pre-surgical serum lipid levels in patients with glioblastoma. Oncotarget 8, 85940–85948, 2017.
   PubMedGoogle Scholar
• Jiang R, Yang ZH, Luo DH, Guo L, Sun R, et al.: Elevated apolipoprotein A-I levels are associated with favorable prognosis in metastatic nasopharyngeal carcinoma. Med Oncol 31, 80, 2014.
   PubMed Web of Science ®Google Scholar
• Stang A: Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25, 603–605, 2010.
   PubMed Web of Science ®Google Scholar
• Zhang JQ, Geng H, Ma M, Nan XY, and Sheng BW: Metabolic syndrome components are associated with increased prostate cancer risk. Med Sci Monit 21, 2387–2396, 2015.
   PubMed Web of Science ®Google Scholar
• Furberg AS, Veierod MB, Wilsgaard T, Bernstein L, and Thune I: Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst 96, 1152–1160, 2004.
   PubMed Web of Science ®Google Scholar
• Ahn J, Lim U, Weinstein SJ, Schatzkin A, Hayes RB, et al.: Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer. Cancer Epidemiol Biomarkers Prevent 18, 2814–2821, 2009.
   PubMed Web of Science ®Google Scholar
• Liao F, He W, Jiang C, Yin C, Guo G, et al.: A high LDL-C to HDL-C ratio predicts poor prognosis for initially metastatic colorectal cancer patients with elevations in LDL-C. Onco Targets Ther 8, 3135–3142, 2015.
   PubMed Web of Science ®Google Scholar
• Campagnoli C, Pasanisi P, Castellano I, Abba C, Brucato T, et al.: Postmenopausal breast cancer, androgens, and aromatase inhibitors. Breast Cancer Res. Treat 139, 1–11, 2013.
   PubMed Web of Science ®Google Scholar
• Nelson ER, Chang CY, and McDonnell DP: Cholesterol and breast cancer pathophysiology. Trends Endocrinol Metab 25, 649–655, 2014.
   PubMed Web of Science ®Google Scholar
• Fedida-Metula S, Feldman B, Koshelev V, Levin-Gromiko U, Voronov E, et al.: Lipid rafts couple store-operated Ca2+ entry to constitutive activation of PKB/Akt in a Ca2+/calmodulin-, Src- and PP2A-mediated pathway and promote melanoma tumor growth. Carcinogenesis 33, 740–750, 2012.
   PubMed Web of Science ®Google Scholar
• Mollinedo F, and Gajate C: Lipid rafts as major platforms for signaling regulation in cancer. Adv Biol Regul 57, 130–146, 2015.
   PubMedGoogle Scholar
• Stopsack KH, Gerke TA, Andren O, Andersson SO, Giovannucci EL, et al.: Cholesterol uptake and regulation in high-grade and lethal prostate cancers. Carcinogenesis 38, 806–811, 2017.
   PubMed Web of Science ®Google Scholar
• Solomon KR, and Freeman MR: Do the cholesterol-lowering properties of statins affect cancer risk? Trends Endocrinol Metab 19, 113–121, 2008.
   PubMed Web of Science ®Google Scholar
• Banker DE, Mayer SJ, Li HY, Willman CL, Appelbaum FR, et al.: Cholesterol synthesis and import contribute to protective cholesterol increments in acute myeloid leukemia cells. Blood 104, 1816–1824, 2004.
   PubMed Web of Science ®Google Scholar
• Kwiterovich PO, Jr.: The metabolic pathways of high-density lipoprotein, low-density lipoprotein, and triglycerides: a current review. Am J Cardiol 86, 5–10L, 2000.
   PubMed Web of Science ®Google Scholar
• Nikkila M, and Heikkinen J: High-density lipoprotein cholesterol and longevity. Age Ageing 19, 119–124, 1990.
   PubMed Web of Science ®Google Scholar
• Jafri H, Alsheikh-Ali AA, and Karas RH: Baseline and on-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapy. J Am Coll Cardiol 55, 2846–2854, 2010.
   PubMed Web of Science ®Google Scholar
• Melvin JC, Holmberg L, Rohrmann S, Loda M, and Van Hemelrijck M: Serum lipid profiles and cancer risk in the context of obesity: four meta-analyses. J Cancer Epidemiol 2013, 823–849, 2013.
   Google Scholar
• Nicholls SJ, Dusting GJ, Cutri B, Bao S, Drummond GR, et al.: Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits. Circulation 111, 1543–1550, 2005.
   PubMed Web of Science ®Google Scholar
• Yvan-Charvet L, Wang N, and Tall AR: Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arterioscler Thromb Vasc Biol 30, 139–143, 2010.
   PubMed Web of Science ®Google Scholar
• Lim U, Gayles T, Katki HA, Stolzenberg-Solomon R, Weinstein SJ, et al.: Serum high-density lipoprotein cholesterol and risk of non-hodgkin lymphoma. Cancer Res 67, 5569–5574, 2007.
   PubMed Web of Science ®Google Scholar
• Spieker LE, Ruschitzka F, Luscher TF, and Noll G: HDL and inflammation in atherosclerosis. Curr Drug Targets Immune Endocr Metabol Disord 4, 51–57, 2004.
   PubMedGoogle Scholar
• Jacobs EJ, and Gapstur SM: Cholesterol and cancer: answers and new questions. Cancer Epidemiol Biomarkers Prev 18, 2805–2806, 2009.
   PubMed Web of Science ®Google Scholar
• Calabresi L, Rossoni G, Gomaraschi M, Sisto F, Berti F, et al.: High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor-alpha content and enhancing prostaglandin release. Circ Res 92, 330–337, 2003.
   PubMed Web of Science ®Google Scholar
• Guyton KZ, and Kensler TW: Oxidative mechanisms in carcinogenesis. Br Med Bull 49, 523–544, 1993.
   PubMed Web of Science ®Google Scholar
• Uchida K: 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res 42, 318–343, 2003.
   PubMed Web of Science ®Google Scholar
• Chung FL, Nath RG, Ocando J, Nishikawa A, and Zhang L: Deoxyguanosine adducts of t-4-hydroxy-2-nonenal are endogenous DNA lesions in rodents and humans: detection and potential sources. Cancer Res 60, 1507–1511, 2000.
   PubMed Web of Science ®Google Scholar
• Sanchez-Perez Y, Carrasco-Legleu C, Garcia-Cuellar C, Perez-Carreon J, Hernandez-Garcia S, et al.: Oxidative stress in carcinogenesis. Correlation between lipid peroxidation and induction of preneoplastic lesions in rat hepatocarcinogenesis. Cancer Lett 217, 25–32, 2005.
   PubMed Web of Science ®Google Scholar
• Dessi S, Batetta B, Pulisci D, Spano O, Anchisi C, et al.: Cholesterol content in tumor tissues is inversely associated with high-density lipoprotein cholesterol in serum in patients with gastrointestinal cancer. Cancer 73, 253–258, 1994.
   PubMed Web of Science ®Google Scholar
• Schorghofer D, Kinslechner K, Preitschopf A, Schutz B, Rohrl C, et al.: The HDL receptor SR-BI is associated with human prostate cancer progression and plays a possible role in establishing androgen independence. Reprod Biol Endocrinol 13, 88, 2015.
   PubMed Web of Science ®Google Scholar
• Li J, Wang J, Li M, Yin L, Li XA, et al.: Up-regulated expression of scavenger receptor class B type 1 (SR-B1) is associated with malignant behaviors and poor prognosis of breast cancer. Pathol Res Pract 212, 555–559, 2016.
   PubMed Web of Science ®Google Scholar
• Nara-Ashizawa N, Akiyama Y, Maruyama K, Tsukada T, and Yamaguchi K: Lipolytic and lipoprotein lipase (LPL)-inhibiting activities produced by a human lung cancer cell line responsible for cachexia induction. Anticancer Res 21, 3381–3387, 2001.
   PubMed Web of Science ®Google Scholar
• Wu P, Wu D, Li L, Chai Y, and Huang J: PD-L1 and survival in solid tumors: a meta-analysis. PLoS One 10, e01314032015.
   PubMed Web of Science ®Google Scholar
• Shao Y, Geng Y, Gu W, Ning Z, Jiang J, et al.: Prognostic role of high Bmi-1 expression in Asian and Caucasian patients with solid tumors: a meta-analysis. Biomed Pharmacother 68, 969–977, 2014.
   PubMed Web of Science ®Google Scholar
• Zhang J, Li B, Yang Q, Zhang P, and Wang H: Prognostic value of Aurora kinase A (AURKA) expression among solid tumor patients: a systematic review and meta-analysis. Jpn J Clin Oncol 45, 629–636, 2015.
   PubMed Web of Science ®Google Scholar
• Song X, Shao Y, Gu W, Xu C, Mao H, et al.: Prognostic role of high B7-H4 expression in patients with solid tumors: a meta-analysis. Oncotarget 7, 76523–76533, 2016.
   PubMedGoogle Scholar